CD4+ T-cell-derived IL-10 promotes CNS inflammation in mice by sustaining effector T cell survival.

[1]  K. Garcia,et al.  Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10 , 2021, Science.

[2]  Steffen Jung,et al.  Interleukin-10 Prevents Pathological Microglia Hyperactivation following Peripheral Endotoxin Challenge. , 2020, Immunity.

[3]  S. Peddada,et al.  Analysis of compositions of microbiomes with bias correction , 2020, Nature Communications.

[4]  T. Bedke,et al.  Title: IL-10-producing T cells and their dual functions. , 2019, Seminars in immunology.

[5]  Deepali V. Sawant,et al.  Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion , 2019, Nature Immunology.

[6]  J. Gustafsson,et al.  Molecular and functional heterogeneity of IL-10-producing CD4+ T cells , 2018, Nature Communications.

[7]  H. Ueno,et al.  A CD4+ T cell population expanded in Lupus blood provides B cell help through IL10 and succinate , 2018, Nature Medicine.

[8]  David M. Schauder,et al.  Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection , 2018, Nature Communications.

[9]  H. Ueno,et al.  A CD4+ T cell population expanded in Lupus blood provides B cell help through IL10 and succinate , 2018, Nature Medicine.

[10]  G. Gusarova,et al.  Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution , 2018, Immunity.

[11]  M. Olszewski,et al.  Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection , 2018, The Journal of Immunology.

[12]  R. Flavell,et al.  Role of IL-10 Receptor Signaling in the Function of CD4+ T-Regulatory Type 1 cells: T-Cell Therapy in Patients with Inflammatory Bowel Disease. , 2018, Critical reviews in immunology.

[13]  S. Snapper,et al.  Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages , 2017, Science.

[14]  W. Yao,et al.  Interleukin-10 reorganizes the cytoskeleton of mature dendritic cells leading to their impaired biophysical properties and motilities , 2017, PloS one.

[15]  A. Waisman,et al.  TGF-β inhibitor Smad7 regulates dendritic cell-induced autoimmunity , 2017, Proceedings of the National Academy of Sciences.

[16]  Francis J. Huber,et al.  IL-10 Receptor Signaling Is Essential for TR1 Cell Function In Vivo , 2017, The Journal of Immunology.

[17]  M. Fathy,et al.  Association of IL-10 gene polymorphisms and susceptibility to Juvenile Idiopathic Arthritis in Egyptian children and adolescents: a case-control study , 2017, Italian Journal of Pediatrics.

[18]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[19]  Søren Brunak,et al.  Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci , 2016, Nature Genetics.

[20]  G. Lutfalla,et al.  IL10, A Tale of an Evolutionarily Conserved Cytokine across Vertebrates. , 2016, Critical reviews in immunology.

[21]  T. Donner,et al.  Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. , 2015, Cytokine.

[22]  B. Bernstein,et al.  Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation , 2015, Nature.

[23]  P. Vogel,et al.  IL-10 engages macrophages to shift Th17 cytokine dependency and pathogenicity during T cell-mediated colitis , 2014, Nature Communications.

[24]  C. Klein,et al.  Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. , 2014, Immunity.

[25]  G. Friedlander,et al.  Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. , 2014, Immunity.

[26]  B. Grimbacher,et al.  IL-10 in humans: lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. , 2014, Current topics in microbiology and immunology.

[27]  A. Hoerauf,et al.  T‐cell‐derived, but not B‐cell‐derived, IL‐10 suppresses antigen‐specific T‐cell responses in Litomosoides sigmodontis‐infected mice , 2013, European journal of immunology.

[28]  Pelin Yilmaz,et al.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..

[29]  P. Vogel,et al.  This information is current as Central Nervous System Autoimmunity Dynamics and Paradoxically Promotes The T Cell Response to IL-10 Alters Cellular , 2012 .

[30]  T. Mcclanahan,et al.  IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs. , 2012, Cancer research.

[31]  B. Clausen,et al.  IL-10 controls dendritic cell-induced T-cell reactivation in the skin to limit contact hypersensitivity. , 2012, The Journal of allergy and clinical immunology.

[32]  T. Mcclanahan,et al.  IL-10 elicits IFNγ-dependent tumor immune surveillance. , 2011, Cancer cell.

[33]  C. Klein,et al.  IL‐10 and IL‐10 receptor defects in humans , 2011, Annals of the New York Academy of Sciences.

[34]  J. Bluestone,et al.  Control of TH17 cells occurs in the Small Intestine , 2011, Nature.

[35]  Y. Wan,et al.  Memory/effector (CD45RBlo) CD4 T cells are controlled directly by IL-10 and cause IL-22–dependent intestinal pathology , 2011, The Journal of experimental medicine.

[36]  R. Caspi,et al.  Faculty Opinions recommendation of Fate mapping of IL-17-producing T cells in inflammatory responses. , 2011 .

[37]  A. Rudensky,et al.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. , 2011, Immunity.

[38]  Francis J. Huber,et al.  Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. , 2011, Immunity.

[39]  M. Veldhoen,et al.  Fate mapping of interleukin 17-producing T cells in inflammatory responses , 2011, Nature Immunology.

[40]  A. Waisman,et al.  Genetic proof for the transient nature of the Th17 phenotype , 2010, European journal of immunology.

[41]  L. Groebe,et al.  Monocytes/macrophages and/or neutrophils are the target of IL‐10 in the LPS endotoxemia model , 2010, European journal of immunology.

[42]  B. Cai,et al.  Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis , 2010, Molecular Biology Reports.

[43]  A. Schäffer,et al.  Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.

[44]  Gisen Kim,et al.  Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.

[45]  T. Mcclanahan,et al.  The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo , 2009, Nature Immunology.

[46]  E. Riley,et al.  IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.

[47]  E. Chi,et al.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. , 2008, Immunity.

[48]  A. O’Garra,et al.  TH1 cells control themselves by producing interleukin-10 , 2007, Nature Reviews Immunology.

[49]  V. Kuchroo,et al.  Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation , 2007, Nature Medicine.

[50]  Stefan Wirtz,et al.  Chemically induced mouse models of intestinal inflammation , 2007, Nature Protocols.

[51]  C. Loddenkemper,et al.  Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease , 2007, The Journal of experimental medicine.

[52]  F. Sutterwala,et al.  Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. , 2006, Immunity.

[53]  D. Raoult,et al.  The two faces of interleukin 10 in human infectious diseases. , 2006, The Lancet. Infectious diseases.

[54]  K. Foulds,et al.  IL-10 Is Required for Optimal CD8 T Cell Memory following Listeria monocytogenes Infection , 2006, The Journal of Immunology.

[55]  K. Rajewsky,et al.  T Cell–specific Inactivation of the Interleukin 10 Gene in Mice Results in Enhanced T Cell Responses but Normal Innate Responses to Lipopolysaccharide or Skin Irritation , 2004, The Journal of experimental medicine.

[56]  Stefan Wirtz,et al.  TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling , 2004 .

[57]  W. Ip,et al.  Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus , 2004, Genes and Immunity.

[58]  R. Kiesslich,et al.  TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. , 2004, Immunity.

[59]  S. Kotenko,et al.  The expanded family of class II cytokines that share the IL‐10 receptor‐2 (IL‐10R2) chain , 2004, Journal of leukocyte biology.

[60]  David Gray,et al.  B cells regulate autoimmunity by provision of IL-10 , 2002, Nature Immunology.

[61]  K. Asadullah,et al.  Immunomodulation by interleukin-10 therapy decreases the incidence of relapse and prolongs the relapse-free interval in Psoriasis. , 2002, The Journal of investigative dermatology.

[62]  C. Demangel,et al.  Autocrine IL‐10 impairs dendritic cell (DC)‐derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL‐12 production , 2002, European journal of immunology.

[63]  M. Lotze,et al.  Interleukin-10 promotes the maintenance of antitumor CD8(+) T-cell effector function in situ. , 2001, Blood.

[64]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[65]  P. Rutgeerts,et al.  Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease , 2000 .

[66]  T. van der Poll,et al.  Proinflammatory Effects of IL-10 During Human Endotoxemia1 , 2000, The Journal of Immunology.

[67]  H. Weiner,et al.  IL-10 is critical in the regulation of automimmune encephalomyelitis as demonstrated by studies of IL-10 and IL-4 deficient and transgenic mice , 1998, Journal of Neuroimmunology.

[68]  W Sterry,et al.  IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. , 1998, The Journal of clinical investigation.

[69]  Wei Wu,et al.  Identification and functional characterization of a second chain of the interleukin‐10 receptor complex , 1997, The EMBO journal.

[70]  L. Nagelkerken,et al.  IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice. , 1997, International Immunology.

[71]  B. Groner,et al.  IL‐10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes , 1996, FEBS letters.

[72]  C. Brosnan,et al.  IL‐10 fails to abrogate experimental autoimmune encephalomyelitis , 1996, Journal of neuroscience research.

[73]  A. Miyajima,et al.  Functional regions of the mouse interleukin-10 receptor cytoplasmic domain , 1995, Molecular and cellular biology.

[74]  K. Rajewsky,et al.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. , 1995, Nucleic acids research.

[75]  B. Fleischer,et al.  Interleukin‐10 prevents experimental allergic encephalomyelitis in rats , 1994, European journal of immunology.

[76]  Y. Lévy,et al.  Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. , 1994, The Journal of clinical investigation.

[77]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[78]  T. Mosmann,et al.  The role of IL-10 in crossregulation of TH1 and TH2 responses. , 1991, Immunology today.

[79]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.